DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626009615?dgcid=rss_sd_all
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626009615?dgcid=rss_sd_all
“DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.” Molecular Therapy.
@article{article108280,
title = {DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626009615?dgcid=rss_sd_all}
}
Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Madison A. Schaefer, Brandon Wilbanks, Irene K. Yan, Alexis M. Sosic, Julia Driscoll, Rory L. Smoot, Tushar Patel, L. James Maher,...